CME Group Inc (CME)

CME Group Inc. is a financial markets company that operates contract markets for futures and options on futures trading around the world. Through its exchanges and related businesses, the company lists products tied to interest rates, equity indexes, foreign exchange, agricultural commodities, energy, metals, fixed income, and foreign currency. CME Group also provides clearing house services for futures, options, and cleared swap transactions, including clearing, settlement, and contract guarantee functions. In addition, it supplies market data services, including real-time and historical information, to a broad client base that includes professional traders, financial institutions, corporations, investors, manufacturers, producers, governments, and central banks. The company, formerly known as Chicago Mercantile Exchange Holdings Inc., adopted its current name in July 2007 and is headquartered in Chicago, Illinois.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-CME
$290.38
-5.0% Downside
Fair
$316
3.4% Upside
Fair
Good
1.7%
February 10, 2027
25.0x
4.1x
15.8x
109.9 B
110.8 B
3.0%
98.6%
0.6
95.1%
95.7%
Valuation • Fair Value

CME Group Inc (NASDAQ-CME) Fair Value by Valuation Model

Review the available estimates for CME Group Inc (NASDAQ-CME), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$290.38

Estimated downside of 5.0% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$278.39

Discounted cash flow valuation reference.

Ben Graham Formula Value

$135.84

Classic Ben Graham valuation formula reference.

DDM Fair Value

$356.12

Dividend discount model valuation reference.

Comps Fair Value

$280.46

Comparable-company valuation reference.

Analyst Price Target

$316

Analysts imply upside of 3.4%.

How to read these valuation models

Use the 7 available valuation references for CME Group Inc (NASDAQ-CME) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for CME Group Inc (NASDAQ-CME)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

6.958 B

Current operating scale indicator.

Revenue Forecast

7.094 B

Forward revenue estimate.

EBITDA

4.942 B

Current operating profitability reference.

EBITDA Forecast

5.069 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review CME Group Inc (NASDAQ-CME) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for CME Group Inc (NASDAQ-CME)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.35

No elevated caution signal from this screen.

Altman Z-Score

0.6

Lower score that deserves closer risk review.

FCF / Net Income

95.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for CME Group Inc (NASDAQ-CME). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for CME Group Inc (NASDAQ-CME)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

February 10, 2027

Days to Earnings

109

Dividend Yield

1.7%

Current income yield reference.

Payout Ratio

95.1%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for CME Group Inc (NASDAQ-CME), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

CME Group Inc (NASDAQ-CME) Stock Forecast & Technical Outlook

Review CME Group Inc (NASDAQ-CME) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for CME Group Inc (NASDAQ-CME) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for CME Group Inc (NASDAQ-CME) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for CME Group Inc (NASDAQ-CME) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for CME Group Inc (NASDAQ-CME) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for CME Group Inc (NASDAQ-CME) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for CME Group Inc (NASDAQ-CME)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, CME Group Inc (NASDAQ-CME) has a Hold consensus, with 4 buy, 6 hold and 1 sell recommendations in the current data set.

Buy 4
Hold 6
Sell 1
FAQ • Fast Investor Answers

CME Group Inc (NASDAQ-CME) Stock FAQ

Data-supported answers about CME Group Inc (NASDAQ-CME), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$290.38
Estimated downside 5.0%
Valuation Rating
Overvalued
Estimated downside of 5.0%
Analyst Target
$316
Implied upside 3.4%
Financial Health
Good
Current financial-health read

The current fair value estimate for CME Group Inc (NASDAQ-CME) is $290.38. This implies an estimated downside of 5.0% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 5.0% versus the current market price.

The available analyst price target for CME Group Inc (NASDAQ-CME) is $316. The analyst target implies estimated upside of 3.4%.

The current financial health read for CME Group Inc (NASDAQ-CME) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for CME Group Inc (NASDAQ-CME) is February 10, 2027.

Based on the current data, dividend yield is 1.7%.

The current P/E ratio listed for CME Group Inc (NASDAQ-CME) is 25.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for CME Group Inc is 109.9 B.

The current enterprise value listed for CME Group Inc is 110.8 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for CME Group Inc is NASDAQ-CME, and the stock is listed on NASDAQ.

CME Group Inc (NASDAQ-CME) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for CME Group Inc is 3.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for CME Group Inc is 98.6%. Free float helps investors understand how much of the share base is available for public trading.